These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2061619)

  • 1. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 and its receptor in the immune response and hematopoiesis.
    Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 and plasma cell neoplasias.
    Hirano T; Kishimoto T
    Prog Growth Factor Res; 1989; 1(3):133-42. PubMed ID: 2491260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma.
    Suematsu S; Hibi M; Sugita T; Saito M; Murakami M; Matsusaka T; Matsuda T; Hirano T; Taga T; Kishimoto T
    Curr Top Microbiol Immunol; 1990; 166():13-22. PubMed ID: 2073791
    [No Abstract]   [Full Text] [Related]  

  • 6. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines as autocrine growth factors in malignancies.
    Kawano M; Kuramoto A; Hirano T; Kishimoto T
    Cancer Surv; 1989; 8(4):905-19. PubMed ID: 2701735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma.
    Barillé S; Bataille R; Amiot M
    Eur Cytokine Netw; 2000 Dec; 11(4):546-51. PubMed ID: 11125296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic and clinical aspects of IL-6].
    Nakajima K; Hirano T
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).
    Akira S; Hirano T; Taga T; Kishimoto T
    FASEB J; 1990 Aug; 4(11):2860-7. PubMed ID: 2199284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
    Gadó K; Domján G; Hegyesi H; Falus A
    Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation.
    Taga T; Kishimoto T
    Crit Rev Immunol; 1992; 11(5):265-80. PubMed ID: 1642780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and its relation to inflammation and disease.
    Hirano T
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin 6 in plasmacytomagenesis.
    Hirano T; Suematsu S; Matsusaka T; Matsuda T; Kishimoto T
    Ciba Found Symp; 1992; 167():188-96; discussion 196-200. PubMed ID: 1425013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
    Treon SP; Anderson KC
    Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifunctional cytokine (IL-6/BSF-2) and its receptor.
    Hirano T; Taga T; Yamasaki K; Matsuda T; Tang B; Muraguchi A; Horii Y; Suematsu S; Hirata Y; Yawata H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):29-33. PubMed ID: 2651317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
    Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G; Musiani P; Poli V
    Am J Pathol; 1997 Sep; 151(3):689-96. PubMed ID: 9284817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.